Form 4 for LFMD LifeMD, Inc.
Accepted 2022-12-23 00:00:00 ET · period of report 2022-12-15 · accession 0001362118-22-000073 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-12-23 | 2022-12-15 | LFMD | Walsh Kathleen E | Dir | A - Grant | — | +75.0K | 75.0K | New | — |
| D | 2022-12-23 | 2022-12-15 | LFMD | Walsh Kathleen E | Dir | A - Grant | $0.00 | +37.5K | 37.5K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-12-15 | A | A | 75,000 | — | 75,000 | D | — | — | (F1) Pursuant to the Company's 2020 Equity and Incentive Plan, as amended, the Director received a one-time grant of 75,000 restricted shares, with 37,500 shares vesting immediately and the remaining 37,500 shares vesting on December 15, 2024. |
| 2 | Derivative | Stock Option (Right to Buy) | 2022-12-15 | A | A | 37,500 | $0.00 | 37,500 | D | $2.30 · — to 2027-12-15 | 37,500 Common Stock | (F2) The option vests on December 15, 2024. |